Polymeric synthetic nanoparticles for the induction of antigen-specific immunological tolerance
about
The rise of food allergy: Environmental factors and emerging treatmentsBiomimetic and synthetic interfaces to tune immune responsesSynthetic Nanoparticles for Vaccines and ImmunotherapyNanoparticles and direct immunosuppressionTowards programming immune tolerance through geometric manipulation of phosphatidylserine.An Antigen-Presenting and Apoptosis-Inducing Polymer Microparticle Prolongs Alloskin Graft Survival by Selectively and Markedly Depleting Alloreactive CD8+ T CellsPlant-based oral tolerance to hemophilia therapy employs a complex immune regulatory response including LAP+CD4+ T cellsCellular and molecular targeting for nanotherapeutics in transplantation tolerance.Harnessing nanoparticles for immune modulationControlled release strategies for modulating immune responses to promote tissue regenerationBeyond antigens and adjuvants: formulating future vaccines.A biodegradable killer microparticle to selectively deplete antigen-specific T cells in vitro and in vivo.Immune Tolerance for Autoimmune Disease and Cell TransplantationBiodegradable antigen-associated PLG nanoparticles tolerize Th2-mediated allergic airway inflammation pre- and postsensitization.Extra-thymically induced T regulatory cell subsets: the optimal target for antigen-specific immunotherapy.In vivo induction of regulatory T cells for immune tolerance in hemophilia.Not just for tumor targeting: unmet medical needs and opportunities for nanomedicine.Nanotechnology for protein delivery: Overview and perspectives.Advancing drug delivery systems for the treatment of multiple sclerosis.Tolerogenic Nanoparticles to Treat Islet Autoimmunity.A pilot study on using rapamycin-carrying synthetic vaccine particles (SVP) in conjunction with enzyme replacement therapy to induce immune tolerance in Pompe disease.Combinatorial drug delivery approaches for immunomodulation.Encapsulating an Immunosuppressant Enhances Tolerance Induction by Siglec-Engaging Tolerogenic Liposomes.Red blood cells: Supercarriers for drugs, biologicals, and nanoparticles and inspiration for advanced delivery systems.Nanomedicines for renal disease: current status and future applicationsRecent advances in the use of nanoparticles for allergen-specific immunotherapy.Tissue Engineering Approaches to Modulate the Inflammatory Milieu following Spinal Cord Injury.Paracrine co-delivery of TGF-β and IL-2 using CD4-targeted nanoparticles for induction and maintenance of regulatory T cells.Regulatory T cell-based therapies for autoimmunity.In vivo reprogramming of immune cells: Technologies for induction of antigen-specific tolerance.Complexity of immune responses to AAV transgene products - Example of factor IX.Antigen-specific immunotherapies in rheumatic diseases.A STING-activating nanovaccine for cancer immunotherapy.Nano- and micro-based systems for immunotolerance induction in multiple sclerosis.Reprogramming the Local Lymph Node Microenvironment Promotes Tolerance that Is Systemic and Antigen SpecificA Novel Approach to Reinstating Tolerance in Experimental Autoimmune Myasthenia Gravis Using a Targeted Fusion Protein, mCTA1-T146.Innovative Approaches for Immune Tolerance to Factor VIII in the Treatment of Hemophilia A.Tolerogenic nanoparticles restore the antitumor activity of recombinant immunotoxins by mitigating immunogenicity.Tolerogenic Ag-PLG nanoparticles induce tregs to suppress activated diabetogenic CD4 and CD8 T cells.Combined Active Humoral and Cellular Immunization Approaches for the Treatment of Synucleinopathies.
P2860
Q26744294-A9972548-FD46-4D62-A32A-72742097AFEDQ26801229-35AEDAFF-799E-40D4-985D-D142168D6270Q28085375-6ABBB548-14B7-42BD-9A11-66AFF2F17993Q28384480-94FCBDFB-E33D-4BA1-8867-EACD2C41DE6DQ30751004-CFD61D7E-5BDB-4948-9093-753180A4E48FQ33780582-88C51A7E-7EDD-4A6B-AEC8-407754BC1F35Q35348677-B5373324-A575-40AA-A1A5-9D0B13C3F570Q36011368-0CE0F5FB-4B2F-46AC-B8CD-58749920B1D7Q36154772-7E82B12B-D8B2-440F-BF89-02E28F4C39CBQ36307642-C71E38D5-1B04-4A5F-B388-FDDD34987378Q36618500-CE407DA0-B728-407B-BA66-72A665A72877Q37022139-8E7651EE-6AB2-420E-BE55-00B8B3F4EA4FQ37099107-FCC126EB-CC8E-4D27-AE94-853BAC0BB90FQ37173058-9CE86DE2-2A94-4CA1-B221-00B811B4ACE7Q38365254-4844EF37-0D6C-4AD6-80A4-5AB574E0EF27Q38574966-1FD17F4A-14B2-4964-BF52-6E1B169EEDA2Q38602136-8EDB93E8-B4B4-495F-B802-B74556BC58F1Q38605185-AB45667E-8776-40A1-B6D0-7E9348CF56D8Q38609620-840A0652-7795-49CF-A45C-A8D540F3821BQ38645059-2749F5D3-62BC-4E9A-A50E-FBDA5C9380EBQ38650286-4924C19A-36F7-4E9C-BA19-8E9753A8A726Q38680602-7BEE6B7F-4A69-4A82-B57C-F2A05ED57B44Q38754057-74D61659-7C97-4FA9-AD1C-A396F29C4213Q38760096-5CCA7678-6765-4294-B8C4-84AF5466EFCBQ38802375-25558122-677D-44FE-B386-912DB3B4AAABQ38802840-297649DA-CC73-46F7-8716-D2ADED846A71Q38811130-C246142F-F5ED-4350-8B60-0A67C8D2D110Q38874906-116AF3D6-1466-4BDE-B334-60FCFA18422CQ38943933-1CC11830-0D6A-4D51-90AE-6D533B1E0BC8Q39245827-1B5F33E9-550D-429A-A733-D5375ACB6A25Q39394803-0E93D2F2-6840-4B63-A435-DF446ABCB33CQ39431371-69734218-75B0-4CD6-9193-A0DF260E604DQ40230470-2A9D7ECF-2036-49AE-889B-9AC1809CD0CBQ40786516-E7D97294-5B92-4956-95A0-790FCD2D06AEQ41101351-664DA0BC-6C1A-4BE7-B2B7-44BF3F6D4E17Q41673068-C87A46F8-1048-4813-B331-7A7107A8E991Q45875675-095618CF-410F-445E-8116-A1949F51C0E3Q47222860-84AB92D8-68E6-4F4E-BA5F-300852262111Q47234002-9D356D97-1E31-4DC5-AC1C-105D6DF3402CQ47563994-AA975274-2D40-4C15-99AC-ABCBBF9D73C8
P2860
Polymeric synthetic nanoparticles for the induction of antigen-specific immunological tolerance
description
2014 nî lūn-bûn
@nan
2014 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
name
Polymeric synthetic nanopartic ...... ecific immunological tolerance
@ast
Polymeric synthetic nanopartic ...... ecific immunological tolerance
@en
Polymeric synthetic nanopartic ...... ecific immunological tolerance
@nl
type
label
Polymeric synthetic nanopartic ...... ecific immunological tolerance
@ast
Polymeric synthetic nanopartic ...... ecific immunological tolerance
@en
Polymeric synthetic nanopartic ...... ecific immunological tolerance
@nl
prefLabel
Polymeric synthetic nanopartic ...... ecific immunological tolerance
@ast
Polymeric synthetic nanopartic ...... ecific immunological tolerance
@en
Polymeric synthetic nanopartic ...... ecific immunological tolerance
@nl
P2093
P2860
P356
P1476
Polymeric synthetic nanopartic ...... ecific immunological tolerance
@en
P2093
Aaron P Griset
Ai-Hong Zhang
Conlin O'Neil
David H Altreuter
David W Scott
Erica Browning
Joseph D Ferrari
Lloyd Johnston
Omid C Farokhzad
Pallavi N Kolte
P2860
P304
P356
10.1073/PNAS.1408686111
P407
P577
2014-12-29T00:00:00Z